Englander Institute for Precision Medicine

Engineered microscale hydrogels for drug delivery, cell therapy, and sequencing.

TitleEngineered microscale hydrogels for drug delivery, cell therapy, and sequencing.
Publication TypeJournal Article
Year of Publication2019
AuthorsWechsler ME, Stephenson RE, Murphy AC, Oldenkamp HF, Singh A, Peppas NA
JournalBiomed Microdevices
Volume21
Issue2
Pagination31
Date Published2019 Mar 23
ISSN1572-8781
KeywordsCell- and Tissue-Based Therapy, Drug Delivery Systems, Engineering, Humans, Hydrogels, Microtechnology, Sequence Analysis
Abstract

Engineered microscale hydrogels have emerged as promising therapeutic approaches for the treatment of various diseases. These microgels find wide application in the biomedical field because of the ease of injectability, controlled release of therapeutics, flexible means of synthesis, associated tunability, and can be engineered as stimuli-responsive. While bulk hydrogels of several length-scale dimensions have been used for over two decades in drug delivery applications, their use as microscale carriers of drug and cell-based therapies is relatively new. Herein, we critically summarize the fundamentals of hydrogels based on their equilibrium and dynamics of their molecular structure, as well as solute diffusion as it relates to drug delivery. In addition, examples of common microgel synthesis techniques are provided. The ability to tune microscale hydrogels to obtain controlled release of therapeutics is discussed, along with microgel considerations for cell encapsulation as it relates to the development of cell-based therapies. We conclude with an outlook on the use of microgels for cell sequencing, and the convergence of the use of microscale hydrogels for drug delivery, cell therapy, and cell sequencing based systems.

DOI10.1007/s10544-019-0358-0
Alternate JournalBiomed Microdevices
PubMed ID30904963
PubMed Central IDPMC6615733
Grant ListR01 AI132738 / AI / NIAID NIH HHS / United States
R01 EB022025 / EB / NIBIB NIH HHS / United States
R33 CA212968 / CA / NCI NIH HHS / United States

Weill Cornell Medicine Englander Institute for Precision Medicine 413 E 69th Street
Belfer Research Building
New York, NY 10021